Digitek MDL Established

The United States Judicial Panel on Multidistrict Litigation has ordered that all federal lawsuits related to defective, double strength Digitek (commonly known as Digitalis or Digoxin ) be moved to the U.S. District Court for the Southern District of West Virginia. This consolidation comes after an April 2008 recall on all lots of the prescription drug after discovery that some tablets twice as thick as normal contained double the appropriate amount of medication.

60+ Digitek Lawsuits Filed 
 
At least 60 Digitek lawsuits have been filed in federal courts across the country. Defendants include Actavis Totowa, LLC, Actavis, Inc., Actavis Elizabeth, LLC, Actavis US, Mylan, Inc., Mylan Pharmaceuticals, Inc., Mylan Laboratories, Inc., Mylan Bertek Pharmaceuticals and UDL Laboratories, Inc.
 
Seventeen of the pending federal suits have been filed in the Southern and Northern District of West Virginia. The other pending cases come from Cleveland, Ohio; New Orleans, La.; Chicago, Ill.; Philadelphia, Pa.; Ft. Myers, Fla.; and Kansas City, Mo.

Digitek Lawsuits - Contact a Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis digoxin toxicity or an overdose of Digitek, please call us immediately for a Free Digitek Recall Lawsuit Evaluation at 1-800-883-9858 or learn more information on whether your case should be filed as a separate lawsuit or part of a global Digitek Class Action Lawsuit and more about the MDL formed recently as described above.

Nationwide Help is Available - Call us at 1-800-883-9858

Good Manufacturing Practice by Actavis

"Good Manufacturing Practice (GMP) is a regulatory guideline imposed on all manufacturers of pharmaceuticals to ensure that finished products have the identity, strength, quality and purity they are required to have.

GMP describes the methods, the controls, the equipment and facilities that must be put into place for the manufacturing of pharmaceutical products. Actavis' ongoing auditing programme verifies adherence to GMP, appropriate training of employees and that resources are being utilised as efficiently as possible."

_______________________________________

" Let's take Actavis to task and see if they met their own standard (above) when it comes to Good Manufacturing Practices in the making of Digitek...I think they will miserably fail their own standard......" 

David Willis - Trial Lawyer - Houston, Texas

Actavis Quality and compliance

Effective quality management is of paramount importance to Actavis' success.

Actavis has prepared a Corporate Manual that sets the standard of performance for all Actavis operations. The manual outlines Actavis' quality management system and environmental, health and safety (EHS) management system.

The implementation of an effective quality management system at each site according to the requirements in the Corporate Manual is supported by the Actavis Quality & Compliance team. The status and performance at each site is then closely monitored by the Actavis Quality Board.

Actavis has manufacturing operations in numerous different countries with diverse regulatory requirements. In order to ensure local compliance our manufacturing sites are all regularly assessed internally and inspected by authorities. Quality audits are undertaken as well, initiated by existing and potential customers.

STANDARDS & COMPLIANCE TO EXCELLENCE IN ACTAVIS' OWN WORDS

May 16, 2008

DigitekŪ Safety Warning and Recall Notification

Veterinarians who use the human drug DigitekŪ (digoxin tablets, USP) to treat their patients should be aware of the possibility that the tablet strength may be doubled in the product.  This increase in tablet active ingredient could result in life-threatening adverse drug reactions in some animals.  Digoxin is used in both humans and animals for the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication.  Under the Animal Medicinal Drug Use Clarification Act of 1994 (AMDUCA) veterinarians are allowed to prescribe extralabel uses of certain approved animal drugs and approved human drugs for animals under certain conditions.

Earlier Digitek Recall of April 28, 2008 was announced by the FDA due to serious digitek side effects , digitalis toxicity, bradycardia from digitek and sudden cardiac death.

Digitek Injury & Death Lawsuit - Contact a Digitek Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of digitalis toxicity or an overdose of Digitek, Bertek and/or UDL Digoxin, please contact immediately for a Free Digitek Lawsuit Evaluation or call us at 1-800-883-9858.

Nationwide Help is Available

Digitek Recalled by FDA

Many of our clients did not receive the Digitek recall notice until at least 5-7 days after it had been withdrawn. In fact, some Digitek clients didn't get their Digitek Recall notice for over 2 weeks after the recall. Others still have not received a letter from their pharmacist or from the manufacturer.

Several of our clients problems did not start until after the recall date, but before they got he announcement. Walmart, Rite Aid, Walgreens, CVS, have by far, sent out the most notice letters so far. In fact, our law offcie has even heard from pharmacists, one of which was still selling Digitek over a week after the recall. sadly, his supplier had not informed him of he Digitek recall earlier.

The voluntary all lot recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate.

DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake.

Call our Law Office if we can help you or a Family Member - Call Toll Free 1-800-883-9858

Digitek Lawsuits filed for Digitek, Bertek & UDL Digoxin Injuries & Deaths

Due to large numbers of Digitek users that have experienced digitalis toxicity and others that have lost loved ones due to Digitek overdose / Digitalis Toxicity, the Willis Law Firm is representing dozens of Digitek victims and their families in Digitek lawsuit litigation. We intend to file a Digitek lawsuit against the manufacturers and distributors of Digetek, Bertek & UDL Digoxin products that are included in the FDA recall namely Mylan, Actavis, & UDL.

FDA Recall of Digitek

Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. (See:FDA Recall of Digitek.)

What is Digitek or Digitalis?

DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. FDA has received many reports of serious illnesses and injuries regarding digitalis toxicity. (See:Digitek Overdose Side Effects) The voluntary all lot recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These Digitek tablets may contain two times the approved level of active ingredient than it appropriate.Get more information concerning the Digitec Recall

Digoxin Overdose Death Lawsuit - Contact a Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, Bertek and/or UDL Digoxin, please call us immediately for a Free Digitek Lawsuit Evaluation at 1-800-883-9858.

Nationwide Help is Available

What is Digoxin or Digitalis?

Digoxin also known as Digitalis, is a purified cardiac glycoside extracted from the foxglove plant. It works by affecting certain minerals (sodium and potassium) inside the cells of the heart. This reduces strain on the heart and helps it beat more strongly Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Digoxin preparations are commonly marketed under the trade names Lanoxin, Digitech, and Lanoxicaps.

Digitek Recall

Actavis Totowa LLC, a division of Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan. Digitek lawsuits are being filed

The voluntary recall of Digitek includes all lots, due to the possibility that Digetek tablets were made with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate which can result in digitalis toxicity, nausea, vomiting, dizziness, low blood pressure, cardiac instability, bradycardia and death. DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure

Digitek Lawsuits - Contact a Lawyer

If you or a loved one have been seriously injured or a loved one has died as a result of this digitalis toxicity or an overdose of Digitek, please call us immediately for a Free Digitek Recall Lawsuit Evaluation at 1-800-883-9858 or learn more information on whether your case should be filed as a separate lawsuit or part of a global Digitek Class Action Lawsuit. Get the facts about which is best for you.

Nationwide Help is Available